Early systemic sclerosis: Marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers

Arthritis Research and Therapy

Volumn 15, Issue 3, 2013, Pages

  Valentini, Gabriele ^a   Marcoccia, Antonella ^b   Cuomo, Giovanna ^a   Vettori, Serena ^a   Iudici, Michele ^a   Bondanini, Francesco ^b   Santoriello, Carlo ^c   Ciani, Aldo ^b   Cozzolino, Domenico ^a   De Matteis, Giovanni Maria ^b   Cappabianca, Salvatore ^a   Vitelli, Filiberto ^b   Spanò, Alberto ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b SANDRO PERTINI HOSPITAL   (Italy)

^c Pediatrics O U   (Italy)

Author keywords

carboxyterminal propeptide of collagen I; early systemic sclerosis; nailfold videocapillaroscopy; preclinical organ involvement; puffy fingerscirculating activation markers; Raynaud's phenomenon; soluble E selectin; soluble IL 2 receptor alpha; systemic sclerosis marker autoantibodies

Indexed keywords

AUTOANTIBODY; CARBON MONOXIDE; COLLAGEN TYPE 1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR ALPHA; AUTOANTIGEN; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CAPILLAROSCOPY; CELL ACTIVATION; CONTROLLED STUDY; FEMALE; FIBROMYALGIA; HUMAN; LUNG CAPACITY; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; SCLERODERMA; SYSTEMIC SCLEROSIS; VIDEOCAPILLAROSCOPY; ANGIOSCOPY; ARTHRITIS; BLOOD; DISEASE COURSE; IMMUNOLOGY; LUNG DISEASE; MIDDLE AGED; PATHOLOGY; PREVALENCE; RAYNAUD PHENOMENON; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ARTHRITIS; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG DISEASES; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; PREVALENCE; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

EID: 84878263113     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4236     Document Type: Article

References (28)

1. LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001, 28:1573-1576.
2. Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, Goulet JR, Rich E, Grodzicky T, Raymond Y, Senécal JL. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis. A twenty-year prospective study of 586 patients with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008, 58:3902-3912. 10.1002/art.24038, 19035499.
3. Valentini G, Cuomo G, Abignano G, Petrillo A, Vettori S, Capasso A, Cozzolino D, Del Genio G, Santoriello C. Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features. Rheumatology (Oxford) 2011, 50:317-323.
4. Valentini G, Vettori S, Cuomo G, Iudici M, D'Abrosca V, Capocotta D, Del Genio G, Santoriello C, Cozzolino D. Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement. Arthritis Res Ther 2012, 14:R188. 10.1186/ar4019, 3580584, 22901779.
5. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23:581-590. 10.1002/art.1780230510, 7378088, Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.
6. LeRoy EC, Medsger TA. Raynaud's phenomenon: a proposal for classification. Clin Exp Rheumatol 1992, 10:485-488.
7. Sebastiani M, Manfredi A, Vukatana G, Moscatelli S, Riato L, Bocci M, Iudici M, Principato A, Mazzuca S, Del Medico P, De Angelis R, D'Amico R, Vicini R, Colaci M, Ferri C. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Ann Rheum Dis 2012, 71:67-70. 10.1136/annrheumdis-2011-200022, 21917823.
8. Maricq HR. Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 1981, 24:1159-1165. 10.1002/art.1780240907, 7306237.
9. Scussel-Lonzetti L, Joyal F, Raynauld J-P, Roussin A, Rich E, Goulet JR, Raymond Y, Senécal JL. Predicting mortality in systemic sclerosis. Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2002, 81:154-167.
10. Caramaschi P, Canestrini S, Martinelli N, Volpe A, Pieropan S, Ferrari M, Bambara LM, Carletto A, Biasi D. Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology 2007, 46:1566-1569. 10.1093/rheumatology/kem190, 17693443.
11. Nishimura RA, Miller FA, Callahan MJ, Benassi RC, Seward JB, Tajik AS. Doppler echocardiography: theory, instrumentation, technique and application. Mayo Clin Proc 1985, 60:321-343. 10.1016/S0025-6196(12)60540-0, 3887049.
12. Maione S, Cuomo G, Giunta A, Tanturri de Horatio L, La Montagna G, Manguso F, Alagia I, Valentini G. Echocardiographic alterations in systemic sclerosis. A longitudinal study. Semin Arthritis Rheum 2005, 34:721-727. 10.1016/j.semarthrit.2004.11.001, 15846587.
13. Ogilvie CM, Forster RE, Blakemore WS, Morton JW. A standardized breath holding technique for clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest 1957, 36:1-17. 10.1172/JCI103402, 1072797, 16695816.
14. Steen VD, Owens GR, Fino GJ, Rodnan GP, Medsger TA. Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum 1985, 28:759-767. 10.1002/art.1780280706, 4015723.
15. Kazerooni EA, Martinez FJ, Flint A, Jamadar DA, Gross BH, Spizarny DL, Cascade PN, Whyte RI, Lynch JP, Toews G. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. Am J Roentgenol 1997, 169:977-983.
16. Walker UA, Tyndall A, Czirják L, Denton CP, Farge-Bancel D, Kowal-Bielecka O, Müller-Ladner U, Matucci-Cerinic M, EUSTAR co-authors Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database. Ann Rheum Dis 2009, 68:856-862. 10.1136/ard.2008.091348, 18625615, EUSTAR co-authors.
17. Wells AU, Steen V, Valentini G. Pulmonary complications: one of the most challenging complications of systemic sclerosis. Rheumatology (Oxford) 2009, 48(Suppl 3):40-44.
18. Scheja A, Wildt M, Wollheim FA, Akesson A, Saxne T. Circulating collagen metabolities in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement. Rheumatology 2000, 39:1110-1113. 10.1093/rheumatology/39.10.1110, 11035131.
19. Allanore Y, Borderie D, Lemaréchal H, Cherrau B, Ekindjian OG, Kahan A. Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and and pulmonary involvement in systemic sclerosis. J Rheumatol 2003, 30:68-73.
20. LeRoy EC, Maricq HR, Kahaleh MB. Undifferentiated connective tissue syndromes. Arthritis Rheum 1980, 23:341-343. 10.1002/art.1780230312, 7362686.
21. Ihn H, Sato S, Fujimoto M, Takehara K, Tamaki K. Increased serum levels of soluble vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis. Br J Rheumatol 1998, 37:1188-1192. 10.1093/rheumatology/37.11.1188, 9851267.
22. Degiannis D, Seibold JR, Czarnecki M, Raskova J, Raska K. Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations. Arthritis Rheum 1990, 33:375-380. 10.1002/art.1780330310, 2317223.
23. Englert H, Champion D, Wu JC, Giallussi J, McGrath M, Manolios N. Antitopoisomerase antibody positivity predates nailfold capillaroscopy abnormalities in scleroderma. Postulated classification of 'prescleroderma'. Intern Med J 2011, 41:197-199. 10.1111/j.1445-5994.2010.02381.x, 22747554.
24. Moinzadeh P, Nihtyanova SI, Howell K, Ong VH, Denton CP. Impact of hallmark autoantibody reactivity on early diagnosis of scleroderma. Clin Rev Allergy Immunol 2012,
25. Matucci-Cerinic M, Allanore Y, Czirják L, Tyndall A, Müller-Ladner U, Denton C, Valentini G, Distler O, Fligelstone K, Tyrrel-Kennedy A, Farge D, Kowal-Bielecka O, van den Hoogen F, Cutolo M, Sampaio-Barros PD, Nash P, Takehara K, Furst DE. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis 2009, 68:1377-1380. 10.1136/ard.2008.106302, 19674983.
26. Avouac J, Fransen J, Walker UA, Riccieri V, Smith V, Muller C, Miniati I, Tarner IH, Randone SB, Cutolo M, Allanore Y, Distler O, Valentini G, Czirjak L, Müller-Ladner U, Furst DE, Tyndall A, Matucci-Cerinic M, EUSTAR Group Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 2011, 70:476-481. 10.1136/ard.2010.136929, 21081523, EUSTAR Group.
27. Fransen J, Johnson SR, van den Hoogen F, Baron M, Allanore Y, Carreira PE, Czirják L, Denton CP, Distler O, Furst DE, Gabrielli A, Herrick A, Inanc M, Kahaleh B, Kowal-Bielecka O, Medsger TA, Mueller-Ladner U, Riemekasten G, Sierakowski S, Valentini G, Veale D, Vonk MC, Walker U, Chung L, Clements PJ, Collier DH, Csuka ME, Jimenez S, Merkel PA, Seibold JR, et al. Items for developing revised classification criteria in systemic sclerosis: results of a consensus exercise. Arthritis Care Res 2012, 64:351-357.
28. Johnson SR, Fransen J, Khanna D, Baron M, van den Hoogen F, Medsger TA, Peschken CA, Carreira PE, Riemekasten G, Tyndall A, Matucci-Cerinic M, Pope JE. Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res 2012, 64:358-367.